Related Experiment Video

Updated: Jan 9, 2026

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

10.7K

Post-infection brain atrophy accelerates cognitive and molecular changes underlying dementia

Michael R Duggan1, Pyry N Sipilä2, Zhijian Yang3

  • 1Laboratory of Behavioral Neuroscience, National Institute On Aging, National Institutes of Health, Baltimore, MD, USA. dugganmr@nih.gov.

Alzheimer'S Research & Therapy
|December 5, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
BiomarkersCognitive declineInfectionLongitudinalNeuroimaging

More Related Videos

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

19.0K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.3K

Related Experiment Videos

Last Updated: Jan 9, 2026

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

10.7K
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

19.0K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.3K

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Dementia01:30

Dementia

487
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
487

Articles linked to this work by shared authors, journal, and citation graph.

Assessing Microstructural and Molecular Brain Changes in Early Cognitive Decline Using Multiparametric 3T Magnetic Resonance Imaging.

Neurology international·2026

Plasma inflammatory markers and brain white matter microstructure in late middle-aged and older adults.

Neurobiology of aging·2026

Idiopathic Normal Pressure Hydrocephalus: A Review.

JAMA·2026

Cerebral oxygen extraction fraction as a physiological biomarker in vascular cognitive impairment: A study in older adults enriched for small vessel diseases.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Multi-Domain Gait Profiling in Idiopathic Normal Pressure Hydrocephalus: Differentiating Fall Patterns and Assessing Shunt Responsiveness.

Movement disorders clinical practice·2026

The countdown paradox: time-varying analysis of biomarker-clock age and symptom onset.

medRxiv : the preprint server for health sciences·2026

Herpes simplex virus and kallikrein-related peptidases - a functional connection in Alzheimer's disease.

Alzheimer's research & therapy·2026

Enhancing Alzheimer's disease diagnosis in primary care through targeted screening of people at risk of developing dementia - study design and feasibility assessment of the PREDEM primary care study.

Alzheimer's research & therapy·2026

A third-generation, high-affinity biparatopic anti-tau antibody inhibits intracellular tau aggregation seeded by Alzheimer's brain extracts.

Alzheimer's research & therapy·2026

Association of self-reported hearing loss and tinnitus with brain structure and cognitive function: a population-based cross-sectional analysis from the Study of Health in Pomerania (SHIP).

Alzheimer's research & therapy·2026

The UNC13A cryptic exon associates with cognitive impairment in Alzheimer's disease.

Alzheimer's research & therapy·2026

Semantic fluency predicts survival of memory clinic patients.

Alzheimer's research & therapy·2026

Synergistic effects of cerebrovascular reactivity and gray matter volume on executive function in aging.

Journal of Alzheimer's disease : JAD·2026

Acute Neurological Manifestations in COVID-19 Are Associated With Complement Activation and Glia-Promoted Neuroinflammation.

Journal of medical virology·2026

Repetitive Transcranial Magnetic Stimulation for Refractory, Widespread Complex Regional Pain Syndrome Type II: A Case Report.

Cureus·2026

Identifying poor responders to repetitive transcranial magnetic stimulation using structural brain networks.

Progress in neuro-psychopharmacology & biological psychiatry·2026

14-3-3γ Protects Against Postoperative Cognitive Dysfunction by Regulating Tau Thr205 Phosphorylation and Synaptic Integrity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

A BSCB-Penetrating Nanoplatform for Enhanced Luteolin Delivery in PRMT2-Targeted Epigenetic Therapy of Spinal Cord Injury.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us